Sahil Shrestha, Ajaya Subedi, Shane A. Snyder, Michael J. Angove, Shukra Raj Paudel
The frequent detection of microplastics (MPs) in bottled drinking water underscores the need for effective point-of-use (POU) purification strategies to limit human exposure, particularly given their ability to transport co-contaminants. While metal-organic frameworks (MOFs) have been extensively investigated for MP removal, their application in practical POU drinking water purification remains largely underexplored, especially regarding scalability and delivery of potable water after filtration. In this work, NH2-MIL-101(Fe) MOF is integrated onto a commercial polyvinylidene fluoride (PVDF) ultrafiltration (UF) membrane to develop a Fe-MOF@UF composite for enhanced removal of polyethylene terephthalate (PET)-MP from drinking water. The optimally synthesized Fe-MOF@UF membrane achieved a PET-MP rejection efficacy of ∼94%. Additionally, its practical applicability is validated using commercially available PET-bottled drinking water, confirming the effective removal of MPs while delivering potable water compliant with international drinking water quality standards. Collectively, these outcomes emphasize the first practical viability of MOF-membrane hybrids for POU drinking water treatment. Despite limitations, this research lays a strong groundwork for future efforts toward performance optimization and highlights a viable pathway for scalable, cost-effective, and sustainable MOF-incorporated household MP filtration units.
{"title":"Toward Scalability: Fe-MOF-Based Ultrafiltration Membrane for Effective Microplastics Removal from Drinking Water at Point-of-Use","authors":"Sahil Shrestha, Ajaya Subedi, Shane A. Snyder, Michael J. Angove, Shukra Raj Paudel","doi":"10.1002/gch2.202500559","DOIUrl":"10.1002/gch2.202500559","url":null,"abstract":"<p>The frequent detection of microplastics (MPs) in bottled drinking water underscores the need for effective point-of-use (POU) purification strategies to limit human exposure, particularly given their ability to transport co-contaminants. While metal-organic frameworks (MOFs) have been extensively investigated for MP removal, their application in practical POU drinking water purification remains largely underexplored, especially regarding scalability and delivery of potable water after filtration. In this work, NH<sub>2</sub>-MIL-101(Fe) MOF is integrated onto a commercial polyvinylidene fluoride (PVDF) ultrafiltration (UF) membrane to develop a Fe-MOF@UF composite for enhanced removal of polyethylene terephthalate (PET)-MP from drinking water. The optimally synthesized Fe-MOF@UF membrane achieved a PET-MP rejection efficacy of ∼94%. Additionally, its practical applicability is validated using commercially available PET-bottled drinking water, confirming the effective removal of MPs while delivering potable water compliant with international drinking water quality standards. Collectively, these outcomes emphasize the first practical viability of MOF-membrane hybrids for POU drinking water treatment. Despite limitations, this research lays a strong groundwork for future efforts toward performance optimization and highlights a viable pathway for scalable, cost-effective, and sustainable MOF-incorporated household MP filtration units.</p>","PeriodicalId":12646,"journal":{"name":"Global Challenges","volume":"10 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12780347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun
Hepatocellular carcinoma (HCC) remains the most prevalent primary liver cancer, characterized by alarmingly high mortality rates and low five-year survival outcomes. A significant challenge in HCC management lies in its advanced-stage treatment, with most cases identified at advanced, unresectable stages, resulting in poor prognoses and limited treatment options. Over the last decade, considerable advancements have been made in systemic treatment strategies, notably with the introduction of multi-kinase inhibitors such as sorafenib and lenvatinib, which have redefined the therapeutic landscape for advanced HCC. The emergence of immunotherapy has further revolutionized first-line treatment, bringing new hope with agents like the PD-1 inhibitor nivolumab and the CTLA-4 inhibitor tremelimumab. Moreover, combination regimens such as atezolizumab plus bevacizumab have demonstrated remarkable clinical efficacy, leading to substantial improvements in overall survival and progression-free survival. Despite the availability of multiple treatment options, clinical trial outcomes remain suboptimal. Key challenges persist in the selection and sequencing of therapies, the development of more diversified combination strategies, and the implementation of downstaging approaches for advanced HCC. This paper aims to provide a comprehensive review of the current progress in systemic therapies for HCC, drawing on extensive research findings and clinical trial data to assess their clinical applications and explore potential challenges. By offering a critical analysis of these therapeutic strategies, this paper seeks to furnish valuable insights and references for ongoing research and future clinical practice, ultimately contributing to improved outcomes in HCC management.
{"title":"Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma","authors":"Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun","doi":"10.1002/gch2.202500247","DOIUrl":"https://doi.org/10.1002/gch2.202500247","url":null,"abstract":"<p>Hepatocellular carcinoma (HCC) remains the most prevalent primary liver cancer, characterized by alarmingly high mortality rates and low five-year survival outcomes. A significant challenge in HCC management lies in its advanced-stage treatment, with most cases identified at advanced, unresectable stages, resulting in poor prognoses and limited treatment options. Over the last decade, considerable advancements have been made in systemic treatment strategies, notably with the introduction of multi-kinase inhibitors such as sorafenib and lenvatinib, which have redefined the therapeutic landscape for advanced HCC. The emergence of immunotherapy has further revolutionized first-line treatment, bringing new hope with agents like the PD-1 inhibitor nivolumab and the CTLA-4 inhibitor tremelimumab. Moreover, combination regimens such as atezolizumab plus bevacizumab have demonstrated remarkable clinical efficacy, leading to substantial improvements in overall survival and progression-free survival. Despite the availability of multiple treatment options, clinical trial outcomes remain suboptimal. Key challenges persist in the selection and sequencing of therapies, the development of more diversified combination strategies, and the implementation of downstaging approaches for advanced HCC. This paper aims to provide a comprehensive review of the current progress in systemic therapies for HCC, drawing on extensive research findings and clinical trial data to assess their clinical applications and explore potential challenges. By offering a critical analysis of these therapeutic strategies, this paper seeks to furnish valuable insights and references for ongoing research and future clinical practice, ultimately contributing to improved outcomes in HCC management.</p>","PeriodicalId":12646,"journal":{"name":"Global Challenges","volume":"10 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gch2.202500247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Federica Saitta, Govind Padmakumar, Paula Perez Rodriguez, Paul Procel Moya, Rudi Santbergen, Arno H.M. Smets
Accurate prediction of optical performance in solar cells with multiscale-textured interfaces is essential for optimizing light management in next-generation photovoltaics. For the first time, a systematic validation of two complementary modeling approaches is carried out on experimentally fabricated thin-film silicon (TF Si) solar cells: rigorous coupled-wave analysis (RCWA), offering a full electromagnetic solution but constrained by boundary conditions, and a ray optics model, operating in the refractive regime. The study involves two device architectures: an a-Si:H single-junction cell on commercial Asahi VU-type glass with random nanotextures, and an nc-Si:H single-junction cell on novel micro-periodic honeycomb-textured glass developed in-house. Simulated and measured external quantum efficiency (EQE) and total front reflection losses (1-R) are benchmarked using the root mean squared error (RMSE). The ray model shows deviations of only 2%–6%, comparable to RCWA, while reducing computation time from 1 week to less than 30 min. Applied to an a-Si:H/nc-Si:H tandem device on honeycomb-textured glass, ray optics reproduced the optical response with spectral deviations below 6% and photocurrent mismatch under 0.2 mA/cm2. These findings uniquely establish ray optics, when combined with accurate optical constants and realistic interface morphologies, as a reliable and computationally efficient predictive tool broadly transferable to thin-film technologies, including perovskites.
{"title":"Time-Efficient, Accurate, and Experimentally Grounded Optical Modeling of Multiscale-Textured Thin-Film Solar Cells","authors":"Federica Saitta, Govind Padmakumar, Paula Perez Rodriguez, Paul Procel Moya, Rudi Santbergen, Arno H.M. Smets","doi":"10.1002/gch2.202500448","DOIUrl":"https://doi.org/10.1002/gch2.202500448","url":null,"abstract":"<p>Accurate prediction of optical performance in solar cells with multiscale-textured interfaces is essential for optimizing light management in next-generation photovoltaics. For the first time, a systematic validation of two complementary modeling approaches is carried out on experimentally fabricated thin-film silicon (TF Si) solar cells: rigorous coupled-wave analysis (RCWA), offering a full electromagnetic solution but constrained by boundary conditions, and a ray optics model, operating in the refractive regime. The study involves two device architectures: an a-Si:H single-junction cell on commercial Asahi VU-type glass with random nanotextures, and an nc-Si:H single-junction cell on novel micro-periodic honeycomb-textured glass developed in-house. Simulated and measured external quantum efficiency (EQE) and total front reflection losses (1-R) are benchmarked using the root mean squared error (RMSE). The ray model shows deviations of only 2%–6%, comparable to RCWA, while reducing computation time from 1 week to less than 30 min. Applied to an a-Si:H/nc-Si:H tandem device on honeycomb-textured glass, ray optics reproduced the optical response with spectral deviations below 6% and photocurrent mismatch under 0.2 mA/cm<sup>2</sup>. These findings uniquely establish ray optics, when combined with accurate optical constants and realistic interface morphologies, as a reliable and computationally efficient predictive tool broadly transferable to thin-film technologies, including perovskites.</p>","PeriodicalId":12646,"journal":{"name":"Global Challenges","volume":"10 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gch2.202500448","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daria Talarico, Enrica Fontananova, Teresa Sibillano, Rosaria Ciriminna, Stefania Palermo, Francesco Galiano, Gianluca Di Profio, Alberto Figoli, Giovanna Li Petri, Giuseppe Angellotti, Francesco Meneguzzo, Cinzia Giannini, Mario Pagliaro
The cover image is based on the article CytroCell@Nafion: Enhanced Proton Exchange Membranes by Mario Pagliaro etal., https://doi.org/10.1002/gch2.202500338.